You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Proton beam therapy for a patient with prostatic rhabdomyosarcoma: a case report and review of the literature
- 2. Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties
- 3. AI Can Boost Radiologists' Efficiency Without Sacrificing Accuracy
- 4. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in lung carcinoid patients after receiving curative surgery. A multicentre study
- 5. LUNG CANCER RESEARCH FOUNDATION EXPANDS RESEARCH ADVOCATES
- 6. Results from Phase 1/2 Study of Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) in Patients with Unresectable Locally Advanced or Metastatic Solid Tumors Refractory to Standard Therapies, Published in Journal of Hematology & Oncology
- 7. Kelun-Biotech Announces Breakthrough Therapy Designation Granted for Sacituzumab Tirumotecan (Sac-TMT) in Combination With Tagitanlimab in China for Certain Types of Non-Small Cell Lung Cancer
- 8. IceCure Receives Notice of Patent Allowance in U.S. for a Novel Cryogen Flow Control to Optimize Patient Outcomes
- 9. Celebrity Diagnoses Underscore Rising Breast Cancer Rates in Young Women
- 10. Dual regulation of the cGAS-STING pathway: new targets and challenges for subtype-specific immunotherapy in breast cancer
Last updated at 21:38 GMT
Hot News Makers
Health/Pharma Companies
-
142877.51
-
20848.33
-
18595.87
-
16924.33
-
16796.13
-
16502.70
-
14164.82
-
13075.22
-
11472.39
-
9014.02
Drugs, Treatments, Trials
-
34339.47
-
7467.85
-
7143.16
-
6345.28
-
5457.89
-
4705.78
-
3615.53
-
2283.49
-
2034.84
-
1867.05
Last updated at 21:10 GMT
